MassMutual Private Wealth & Trust’s BridgeBio Pharma BBIO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.54K	Buy	69 +26	+60%	+$2.02K	﹤0.01%	1652
2026 Q2	$3.2K	Buy	43 +6	+16%	+$420	﹤0.01%	1848
2026 Q1	$2.75K	Buy	37 +2	+6%	+$145	﹤0.01%	1889
2025 Q4	$2.68K	Buy	35 +2	+6%	+$131	﹤0.01%	1912
2025 Q3	$1.71K	Hold	33	–	–	﹤0.01%	2028
2025 Q2	$1.43K	Sell	33 -10	-23%	-$364	﹤0.01%	2036
2025 Q1	$1.49K	Buy	+43	New	+$1.45K	﹤0.01%	2012
2022 Q1	–	Sell	-54	Closed	-$1K	–	1513
2021 Q4	$1K	Buy	+54	New	+$2.29K	﹤0.01%	1172

Other funds holding BBIO

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

RWS

Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

MassMutual Private Wealth & Trust's BBIO Position: Q3 2026 in Review

MassMutual Private Wealth & Trust increased its BridgeBio Pharma (BBIO) stake by 60% in Q3 2026, buying an estimated $2.02K and bringing the position to 69 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

MassMutual Private Wealth & Trust first reported a position in BBIO in Q4 2021 and has held it in 8 quarters since. 12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

MassMutual Private Wealth & Trust held 69 shares of BridgeBio Pharma worth $4.54K as of Q3 2026.
MassMutual Private Wealth & Trust bought 26 BridgeBio Pharma shares in Q3 2026, an estimated $2.02K.
BridgeBio Pharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1652 holding.
MassMutual Private Wealth & Trust first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 8 quarters since.
12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.